Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacological chaperones in nephrogenic diabetes insipidus: possibilities for clinical application.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy - 1 Jan 2007

Robben Joris H, Deen Peter M T

Abstract excerpt

The antidiuretic hormone arginine-vasopressin regulates water homeostasis in the human body by binding to its vasopressin type 2 receptor (V2R). Mutations in AVPR2, the gene encoding V2R, lead to the X-linked congenital form of nephrogenic diabetes insipidus (NDI), a disease characterized by the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Sequence
Share to Cysteine
Share to Diabetes Insipidus, Nephrogenic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endoplasmic Reticulum

Share to Molecular Chaperones

Share to Molecular Sequence Data

Share to Protein Folding

Share to Receptors, Vasopressin

Source

Identifiers

PMID: 17516711
DOI: 10.2165/00063030-200721030-00003

Genes

AVPR2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17516711-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacological chaperones in nephrogenic diabetes insipidus: possibilities for clinical application.PMID 17516711Read ↗

Vasopressin receptors and pharmacological chaperones: from functional rescue to promising therapeutic strategies.Semantic proximity Read ↗

Pharmacological Chaperones as Potential Therapeutic Strategies for Misfolded Mutant Vasopressin Receptors.Semantic proximity Read ↗

Potential of nonpeptide (ant)agonists to rescue vasopressin V2 receptor mutants for the treatment of X-linked nephrogenic diabetes insipidus.Semantic proximity Read ↗

Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.Semantic proximity Read ↗

V2 vasopressin receptor mutations: future personalized therapy based on individual molecular biology.Semantic proximity Read ↗

V2 vasopressin receptor mutations.Semantic proximity Read ↗

Nephrogenic diabetes insipidus.Semantic proximity Read ↗

Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus.Semantic proximity Read ↗

Vasopressin receptor mutations in nephrogenic diabetes insipidus.Semantic proximity Read ↗

Evaluation of pharmacochaperone-mediated rescue of mutant V2 receptor proteins.Semantic proximity Read ↗

Misfolding of vasopressin receptors: biased agonist pharmacochaperones as potential therapeutics.Semantic proximity Read ↗

Rescue of vasopressin V2 receptor mutants by chemical chaperones: specificity and mechanism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.